Receptor-associated prorenin system in the pathogenesis of retinal diseases

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 4, 2012, Pages 1449-1460

  Satofuka, Shingo ^a   Kanda, Atsuhiro ^c   Ishida, Susumu ^b,c  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PRORENIN RECEPTOR; RECEPTOR BLOCKING AGENT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; CELL SURFACE RECEPTOR; RENIN;

ARTICLE; DIABETIC MACULAR EDEMA; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; GLOMERULOSCLEROSIS; HUMAN; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETINITIS; SUBRETINAL NEOVASCULARIZATION; UPREGULATION; ANIMAL; METABOLISM; REVIEW;

MURINAE; MUS;

ANIMALS; HUMANS; RECEPTORS, CELL SURFACE; RENIN; RETINAL DISEASES;

EID: 84867573435     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Cruciat, C. M., B. Ohkawara, S. P. Acebron, E. Karaulanov, C. Reinhard, D. Ingelfinger, M. Boutros & C. Niehrs: Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 327, 459-463(2010)
2. Nguyen, G., F. Delarue, C. Burckle, L. Bouzhir, T. Giller & J. D. Sraer: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109, 1417-1427(2002) (Pubitemid 34596167)
3. Huang, Y., N. A. Noble, J. Zhang, C. Xu & W. A. Border: Renin-stimulated TGF-beta1 expression is regulated by a mitogen-Activated protein kinase in mesangial cells. Kidney Int 72, 45-52(2007) (Pubitemid 47014443)
4. Ichihara, A., Y. Kaneshiro, T. Takemitsu, M. Sakoda, T. Nakagawa, A. Nishiyama, H. Kawachi, F. Shimizu & T. Inagami: Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 17, 2495-2503(2006) (Pubitemid 44300965)
5. Kaneshiro, Y., A. Ichihara, M. Sakoda, T. Takemitsu, A. H. Nabi, M. N. Uddin, T. Nakagawa, A. Nishiyama, F. Suzuki, T. Inagami & H. Itoh: Slowly Progressive, Angiotensin II-Independent Glomerulosclerosis in Human (Pro)renin Receptor-Transgenic Rats. J Am Soc Nephrol 18, 1789-1795(2007) (Pubitemid 46870315)
6. Ichihara, A., F. Suzuki, T. Nakagawa, Y. Kaneshiro, T. Takemitsu, M. Sakoda, A. H. Nabi, A. Nishiyama, T. Sugaya, M. Hayashi & T. Inagami: Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 17, 1950-1961(2006) (Pubitemid 44036179)
7. Ichihara, A., M. Hayashi, Y. Kaneshiro, F. Suzuki, T. Nakagawa, Y. Tada, Y. Koura, A. Nishiyama, H. Okada, M. N. Uddin, A. H. Nabi, Y. Ishida, T. Inagami & T. Saruta: Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 114, 1128-1135(2004) (Pubitemid 39578702)
8. Takahashi, H., A. Ichihara, Y. Kaneshiro, K. Inomata, M. Sakoda, T. Takemitsu, A. Nishiyama & H. Itoh: Regression of Nephropathy Developed in Diabetes by (Pro)renin Receptor Blockade. J Am Soc Nephrol 18, 2054-2061(2007) (Pubitemid 47041071)
9. Nagai, N., Y. Oike, K. Izumi-Nagai, T. Urano, Y. Kubota, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, T. Suda & S. Ishida: Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arterioscler Thromb Vasc Biol 26, 2252-2259(2006) (Pubitemid 44465719)
10. Nagai, N., K. Noda, T. Urano, Y. Kubota, H. Shinoda, T. Koto, K. Shinoda, M. Inoue, T. Shiomi, E. Ikeda, K. Tsubota, T. Suda, Y. Oike & S. Ishida: Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci 46, 1078-1084(2005) (Pubitemid 41321048)
11. Satofuka, S., A. Ichihara, N. Nagai, K. Yamashiro, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, F. Suzuki, Y. Oike & S. Ishida: Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci 47, 2686-2692(2006)
12. Satofuka, S., A. Ichihara, N. Nagai, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, H. Itoh, Y. Oike & S. Ishida: Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci 48, 422-429(2007) (Pubitemid 47251433)
13. Satofuka, S., A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, A. Fukamizu, K. Tsubota, H. Itoh, Y. Oike & S. Ishida: (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-Angiotensin system. Am J Pathol 173, 1911-1918(2008)
14. Satofuka, S., A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, A. Fukamizu, K. Tsubota, H. Itoh, Y. Oike & S. Ishida: (Pro)renin receptor-mediated signal transduction and tissue reninangiotensin system contribute to diabetes-induced retinal inflammation. Diabetes 58, 1625-1633(2009)
15. Suzuki, F., M. Hayakawa, T. Nakagawa, U. M. Nasir, A. Ebihara, A. Iwasawa, Y. Ishida, Y. Nakamura & K. Murakami: Human prorenin has "gate and handle" regions for its non-proteolytic activation. J Biol Chem 278, 22217-22222(2003) (Pubitemid 36830267)
16. Ichihara, A., Y. Kaneshiro, T. Takemitsu, M. Sakoda, F. Suzuki, T. Nakagawa, A. Nishiyama, T. Inagami & M. Hayashi: Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47, 894-900(2006) (Pubitemid 44297561)
17. Nurun, N. A., N. M. Uddin, T. Nakagawa, H. Iwata, A. Ichihara, T. Inagami & F. Suzuki: Role of "handle" region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor. Front Biosci 12, 4810-4817(2007)
18. He, M., L. Zhang, Y. Shao, X. Wang, Y. Huang, T. Yao & L. Lu: Inhibition of renin/prorenin receptor attenuated mesangial cell proliferation and reduced associated fibrotic factor release. Eur J Pharmacol 606, 155-161(2009)
19. Ferris, F. L., 3rd, S. L. Fine & L. Hyman: Agerelated macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 102, 1640-1642(1984) (Pubitemid 15204559)
20. Klein, R., Q. Wang, B. E. Klein, S. E. Moss & S. M. Meuer: The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 36, 182-191(1995)
21. Klein, R., B. E. Klein, S. C. Tomany & K. J. Cruickshanks: The association of cardiovascular disease with the long-Term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 110, 1273-1280(2003)
22. van Leeuwen, R., M. K. Ikram, J. R. Vingerling, J. C. Witteman, A. Hofman & P. T. de Jong: Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 44, 3771-3777(2003) (Pubitemid 37047945)
23. Sola, S., M. Q. Mir, F. A. Cheema, N. Khan-Merchant, R. G. Menon, S. Parthasarathy & B. V. Khan: Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 111, 343-348(2005) (Pubitemid 40165342)
24. Ferder, L., F. Inserra & M. Martinez-Maldonado: Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress. Curr Hypertens Rep 8, 191-198(2006) (Pubitemid 43853445)
25. Vaziri, N. D., Z. G. Xu, A. Shahkarami, K. T. Huang, B. Rodriguez-Iturbe & R. Natarajan: Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity. Kidney Int 68, 2787-2793(2005) (Pubitemid 43251024)
26. Brasier, A. R., A. Recinos, 3rd & M. S. Eledrisi: Vascular inflammation and the renin-Angiotensin system. Arterioscler Thromb Vasc Biol 22, 1257-1266(2002) (Pubitemid 34875734)
27. Ishibashi, T., Y. Hata, H. Yoshikawa, K. Nakagawa, K. Sueishi & H. Inomata: Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 235, 159-167(1997) (Pubitemid 27129479)
28. Sakurai, E., H. Taguchi, A. Anand, B. K. Ambati, E. S. Gragoudas, J. W. Miller, A. P. Adamis & J. Ambati: Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 44, 2743-2749(2003) (Pubitemid 36618439)
29. Yeh, D. C., D. V. Bula, J. W. Miller, E. S. Gragoudas & J. G. Arroyo: Expression of leukocyte adhesion molecules in human subfoveal choroidal neovascular membranes treated with and without photodynamic therapy. Invest Ophthalmol Vis Sci 45, 2368-2373(2004) (Pubitemid 38902611)
30. Sakurai, E., A. Anand, B. K. Ambati, N. van Rooijen & J. Ambati: Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44, 3578-3585(2003) (Pubitemid 36909798)
31. Espinosa-Heidmann, D. G., I. J. Suner, E. P. Hernandez, D. Monroy, K. G. Csaky & S. W. Cousins: Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44, 3586-3592(2003) (Pubitemid 36909799)
32. Tsutsumi, C., K. H. Sonoda, K. Egashira, H. Qiao, T. Hisatomi, S. Nakao, M. Ishibashi, I. F. Charo, T. Sakamoto, T. Murata & T. Ishibashi: The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol 74, 25-32(2003) (Pubitemid 38040433)
33. Wilkinson-Berka, J. L., R. Heine, G. Tan, M. E. Cooper, K. M. Hatzopoulos, E. L. Fletcher, K. J. Binger, D. J. Campbell & A. G. Miller: RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina. Hypertension 55, 1454-1460(2010)
34. Nagai, N., K. Izumi-Nagai, Y. Oike, T. Koto, S. Satofuka, Y. Ozawa, K. Yamashiro, M. Inoue, K. Tsubota, K. Umezawa & S. Ishida: Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest Ophthalmol Vis Sci 48, 4342-4350(2007) (Pubitemid 351261068)
35. McLeod, D. S., D. J. Lefer, C. Merges & G. A. Lutty: Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147, 642-653(1995)
36. Miyamoto, K., S. Khosrof, S. E. Bursell, R. Rohan, T. Murata, A. C. Clermont, L. P. Aiello, Y. Ogura & A. P. Adamis: Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A 96, 10836-10841(1999) (Pubitemid 29442230)
37. Aiello, L. P., R. L. Avery, P. G. Arrigg, B. A. Keyt, H. D. Jampel, S. T. Shah, L. R. Pasquale, H. Thieme, M. A. Iwamoto, J. E. Park & et al.: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331, 1480-1487(1994) (Pubitemid 24356306)
38. Tanaka, Y., S. Katoh, S. Hori, M. Miura & H. Yamashita: Vascular endothelial growth factor in diabetic retinopathy. Lancet 349, 1520(1997) (Pubitemid 27216369)
39. Ishida, S., T. Usui, K. Yamashiro, Y. Kaji, E. Ahmed, K. G. Carrasquillo, S. Amano, T. Hida, Y. Oguchi & A. P. Adamis: VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44, 2155-2162(2003)
40. Candido, R., T. J. Allen, M. Lassila, Z. Cao, V. Thallas, M. E. Cooper & K. A. Jandeleit-Dahm: Irbesartan but not amlodipine suppresses diabetesassociated atherosclerosis. Circulation 109, 1536-1542(2004) (Pubitemid 38420183)
41. Tamarat, R., J. S. Silvestre, M. Durie & B. I. Levy: Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor-And inflammationrelated pathways. Lab Invest 82, 747-756(2002) (Pubitemid 34633824)
42. Egami, K., T. Murohara, T. Shimada, K. Sasaki, S. Shintani, T. Sugaya, M. Ishii, T. Akagi, H. Ikeda, T. Matsuishi & T. Imaizumi: Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112, 67-75(2003) (Pubitemid 38056377)
43. Moravski, C. J., D. J. Kelly, M. E. Cooper, R. E. Gilbert, J. F. Bertram, S. Shahinfar, S. L. Skinner & J. L. Wilkinson-Berka: Retinal neovascularization is prevented by blockade of the renin-Angiotensin system. Hypertension 36, 1099-1104(2000)
44. Alcazar, O., S. W. Cousins, G. E. Striker & M. E. Marin-Castano: (Pro)renin receptor is expressed in human retinal pigment epithelium and participates in extracellular matrix remodeling. Exp Eye Res 89, 638-647(2009)
45. Joussen, A. M., V. Poulaki, W. Qin, B. Kirchhof, N. Mitsiades, S. J. Wiegand, J. Rudge, G. D. Yancopoulos & A. P. Adamis: Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 160, 501-509(2002) (Pubitemid 34160327)
46. Joussen, A. M., V. Poulaki, M. L. Le, K. Koizumi, C. Esser, H. Janicki, U. Schraermeyer, N. Kociok, S. Fauser, B. Kirchhof, T. S. Kern & A. P. Adamis: A central role for inflammation in the pathogenesis of diabetic retinopathy. Faseb J 18, 1450-1452(2004) (Pubitemid 39561611)
47. Ishida, S., T. Usui, K. Yamashiro, Y. Kaji, S. Amano, Y. Ogura, T. Hida, Y. Oguchi, J. Ambati, J. W. Miller, E. S. Gragoudas, Y. S. Ng, P. A. D'Amore, D. T. Shima & A. P. Adamis: VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 198, 483-489(2003) (Pubitemid 36976059)
48. Miyamoto, K., N. Hiroshiba, A. Tsujikawa & Y. Ogura: In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci 39, 2190-2194(1998) (Pubitemid 28455092)
49. Funatsu, H., H. Yamashita, T. Ikeda, Y. Nakanishi, S. Kitano & S. Hori: Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol 133, 537-543(2002) (Pubitemid 34258063)
50. Ruiz-Ortega, M., V. Esteban, M. Ruperez, E. Sanchez-Lopez, J. Rodriguez-Vita, G. Carvajal & J. Egido: Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 15, 159-166(2006)
51. Otani, A., H. Takagi, K. Suzuma & Y. Honda: Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 82, 619-628(1998) (Pubitemid 28129033)
52. Matavelli, L. C., J. Huang & H. M. Siragy: (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation. Clin Exp Pharmacol Physiol 37, 277-282(2010)
53. Janka, H. U., J. H. Warram, L. I. Rand & A. S. Krolewski: Risk factors for progression of background retinopathy in longstanding IDDM. Diabetes 38, 460-464(1989) (Pubitemid 19105404)
54. Teuscher, A., H. Schnell & P. W. Wilson: Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 11, 246-251(1988)